QLI Kewajiban utang agregat Qilian International Holding

QLI (Qilian International Holding) - tandha merek perusahaan

The visualization of the market price for Qilian International (QLI) individual debt on the GURU.Markets platform demonstrates metrics at the level of 0.00. Qilian International (QLI) is fighting for influence in the chemical raw materials segment, trailing state-owned entities. The business relies on the production of components for medicine and traditional remedies in the PRC, where cash flows are stable but dependent on government contracts. Control over the value chain for heparin and licorice extracts provides a competitive advantage.

Gunggung utang perusahaan: Qilian International Holding Group Limited (QLI) kanggo 04.07.2022 - 17.08.2024
Sampel barang Qilian International

Stable licenses held by Qilian International (QLI) provide a market priority, yet the necessity of upgrading plants to meet environmental standards requires a significant influx of capital. Analyzing the debt movement chart, an investor can observe the dynamics of total liabilities by comparing credit offerings with the company's demand for loans, which allows for an assessment of default risk and the stability of the issuer's capitalization during periods of macroeconomic instability.

Pesaing utama

Gunggung utang perusahaan HLN (Haleon Corp)|Utang perusahaan Kenvue Inc.|veronapharma.com - Kewajiban utang agregat|MENS: Utang perusahaan|LGND - Gunggung utang perusahaan|AMRX: Gunggung utang perusahaan|Gunggung utang perusahaan Perrigo Corp|ALVO - Gunggung utang perusahaan|Kewajiban utang agregat LQDA|Galapagos - Utang perusahaan|Utang kumulatif perusahaan ANI Pharmaceuticals Inc ANIP|Gunggung utang perusahaan MannKind Corp. (MNKD)|Tanggungan utang kumulatif perusahaan Amphastar Corp AMPH|Gunggung utang perusahaan Pacira BioSciences (PCRX)|SPRY - Kewajiban utang agregat|Gunggung utang perusahaan TBPH|AQST (Aquestive Therapeutics Inc) - Utang kumulatif perusahaan|SCPH - Utang perusahaan|Kewajiban utang agregat TECX|TNXP: Utang perusahaan|Tanggungan utang total perusahaan sxtchina.com (SXTC)|Gunggung utang perusahaan EPRX|BioHarvest Sciences, Inc. - Gunggung kewajiban utang perusahaan|EXOZ - Utang perusahaan|ORMP - Utang perusahaan|enterabio.com - Gunggung utang perusahaan|ipatherapeutics.com (HYFT) - Gunggung kewajiban utang perusahaan|ABVC (ABVC BioPharma, Inc.) - Gunggung utang perusahaan|Gunggung utang perusahaan CPIX|Utang perusahaan Quantum BioPharma Limited QNTM|Utang agregat perusahaan FibroGen Corporation FGEN|Gunggung utang perusahaan Telomir Pharmaceuticals|Kewajiban utang agregat Rani Therapeutics Holdings RANI|Gunggung utang perusahaan SNYR (Synergy CHC Corporation)|RLYB: Gunggung kewajiban utang perusahaan|Utang perusahaan lexariabioscience.com|Utang agregat perusahaan Pulmatrix Corporation|Pheton Holdings Limited (PTHL) - Gunggung utang perusahaan|Tanggungan utang kumulatif perusahaan Aptorum|Lyra Therapeutics - Gunggung utang perusahaan|Utang kumulatif perusahaan IBO (Impact BioMedical, Inc.)|Utang perusahaan TNF Pharmaceuticals, Inc.|cbdMD Inc. - Kewajiban utang agregat|PainReform Ltd. (PRFX) - Utang perusahaan|CYTO - Utang agregat perusahaan|LIPO: Gunggung utang perusahaan|Gunggung utang perusahaan OptiNose Inc|Pieris (PIRS) - Gunggung utang perusahaan|Tanggungan utang kumulatif perusahaan Procaps Group Corp|PTPI (Petros Pharmaceuticals) - Gunggung utang perusahaan|Gunggung kewajiban utang perusahaan SLRN (acelyrin.com)|TFFP: Utang perusahaan